Thalassemia may be too easy to overlook for those in the U.S., but it is an enormous global problem! NOTE: Continuing Education credit for this episode has expired. See below for details. When most United States-based healthcare providers think of a hemoglobinopathy,...
Red cell antibodies should be simple, right? Not always, and the Mighty Monocyte Monolayer Assay may show the way! NOTE: Continuing Education credit for this episode has expired. See below for details. Usually, when a transfusion service or reference laboratory...
Platelet transfusions are life-saving in many situations, but what do you do when they might NOT be helpful? Platelets have been used to save the lives of patients with low platelet counts for decades. For the most part, they are considered a safe and effective means...
What’s new with Low-titer Group O Whole Blood? Dr. Mark Yazer returns to give us the latest. In 2017, Dr. Mark Yazer appeared on this podcast to discuss the burgeoning interest in “Low-titer Group O Whole Blood (LTOWB)” for massive transfusions,...
An expert panel’s 6-year-old recommendations on RHD genotyping are not quite being used as intended. Let’s learn how we can do better! NOTE: Continuing Education credit for this episode has expired. See below for details. Despite guidance in a 2015...
